AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Mesoblast Limited American Depositary Shares
XNAS · usd
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG001SMNB80
12.28▼ 0.27 (-2.15%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
12.55
Day's Range
12.21 – 12.38
52-Week Range
11.89 – 21.50
Volume
102.6K
Avg Volume
240.2K
Share Statistics
Shares Outstanding
Employees
81
Exchange
XNAS
Listed
2009-01-05
Share count as of June 30, 2026

Mesoblast Limited American Depositary Shares (MESO) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Mesoblast Limited American Depositary Shares (MESO)
What is Mesoblast Limited American Depositary Shares's Market Cap?
Mesoblast Limited American Depositary Shares's Market Cap is $15.9B, based on as-reported figures from SEC (XBRL) filings.
What is Mesoblast Limited American Depositary Shares's Enterprise Value?
Mesoblast Limited American Depositary Shares's Enterprise Value is $16.0B, based on as-reported figures from SEC (XBRL) filings.
What is Mesoblast Limited American Depositary Shares's Price / Sales?
Mesoblast Limited American Depositary Shares's Price / Sales is 132.4×, based on as-reported figures from SEC (XBRL) filings.
What is Mesoblast Limited American Depositary Shares's EV / Revenue?
Mesoblast Limited American Depositary Shares's EV / Revenue is 132.7×, based on as-reported figures from SEC (XBRL) filings.
What is Mesoblast Limited American Depositary Shares's EV / EBITDA?
Mesoblast Limited American Depositary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Mesoblast Limited American Depositary Shares's Revenue (TTM)?
Mesoblast Limited American Depositary Shares's Revenue (TTM) is $120.3M, based on as-reported figures from SEC (XBRL) filings.
What is Mesoblast Limited American Depositary Shares's Net Income (TTM)?
Mesoblast Limited American Depositary Shares's Net Income (TTM) is -$57.5M, based on as-reported figures from SEC (XBRL) filings.
What is Mesoblast Limited American Depositary Shares's EBITDA?
Mesoblast Limited American Depositary Shares's EBITDA is -$34.6M, based on as-reported figures from SEC (XBRL) filings.
What is Mesoblast Limited American Depositary Shares's Diluted EPS (TTM)?
Mesoblast Limited American Depositary Shares's Diluted EPS (TTM) is -0.04, based on as-reported figures from SEC (XBRL) filings.
What is Mesoblast Limited American Depositary Shares's EBITDA Margin?
Mesoblast Limited American Depositary Shares's EBITDA Margin is -28.7%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · MESOAs-filed SEC (XBRL) data
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Jun 30, 2025Jun 30, 2024Jun 30, 2023Jun 30, 2022Jun 30, 2021Jun 30, 2020Jun 30, 2019Jun 30, 2018
Profit or loss [abstract]
Product sales, net
Royalty revenue
Total revenues
Cost of revenues (including amortization of currently marketed intangible assets, 2026: $6,126: 2025: $3,937, 2024: $Nil)
Research & development
Selling, general and administration
Fair value remeasurement of contingent consideration
Fair value remeasurement of warrant liability
Other operating income and expenses
Finance costs
Loss before income tax
Income tax (expense)/benefit
Loss attributable to the owners of Mesoblast Limited
Losses per share from continuing operations attributable to the ordinary equity holders of the Group:
Basic - losses per share (in USD per share)
Diluted - losses per share (in USD per share)